EFNA5 and posterior cortical atrophy: However, the average of serum ephrin-A5 concentrations was 3.4 fold higher in metastatic PCa patients (1.01 ± 0.13 ng/ml) compared to non-metastatic PCa patients (0.32 ± 0.038 ng/ml) (Fig. 7C).